Stay updated on LY3454738 in Chronic Urticaria - Clinical Trial
Sign up to get notified when there's something new on the LY3454738 in Chronic Urticaria - Clinical Trial page.

Latest updates to the LY3454738 in Chronic Urticaria - Clinical Trial page
- Check3 days agoChange DetectedThe Locations section has been consolidated and updated to an aggregated list of sites, replacing the previous per-location headers, and the revision changed from v3.3.2 to v3.3.3.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.3.2; removed Revision: v3.2.0.SummaryDifference0.0%

- Check39 days agoChange DetectedThe government funding notice at the top of the page has been removed. Trial details, eligibility criteria, and site locations appear unchanged.SummaryDifference0.3%

- Check53 days agoChange DetectedNo significant changes detected between the screenshots; core study details such as title, conditions, design, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedUpgrade to v3.2.0 is introduced, replacing v3.1.0, plus a government-operating-status notice. This signals a status check for current operations but does not modify concrete content like pricing or stock.SummaryDifference3%

- Check89 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and a prior revision note (Revision: v3.0.2).SummaryDifference0.5%

Stay in the know with updates to LY3454738 in Chronic Urticaria - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3454738 in Chronic Urticaria - Clinical Trial page.